Queensland Clinical Trials and Biostatistics Centre Selects OpenClinica Enterprise Clinical Trial Software

Press Release | The Queensland Clinical Trials & Biostatistics Centre (QCTBC), OpenClinica® | September 4, 2012

Clinical research software platform increases productivity; enables standardization.

OpenClinica, LLC, the provider of commercial open source clinical trial software announces that the Clinical Trials and Biostatistics Centre at the University of Queensland School of Population Health has selected OpenClinica Enterprise as their electronic data capture and clinical data management platform of choice.

The Queensland Clinical Trials & Biostatistics Centre (QCTBC) at the University of Queensland was founded in 2009 to provide high quality research infrastructure that adheres to strict international regulatory requirements. The group manages multicenter and multinational clinical studies and provides services for the design, protocol development, setup, database development, database management, statistical analysis and reporting, as well as the general management of clinical trials in a range of disease areas.

“Given the diversity and complexity of our clinical studies, OpenClinica was a natural fit,” said Dr. Sanjoy Paul, Director of the QCTBC. “It allows us to cost effectively undertake a wide range of projects on a robust, regulatory compliant data capture and data management system. We can standardize our expertise on a single platform while having greater control over building and managing studies.”

As commercial open source software, OpenClinica is provided in two editions: the freely available OpenClinica Community Edition, and the commercially supported OpenClinica Enterprise Edition. The software is web-based, with a modern architecture and support for leading standards. More at http://www.openclinica.com.

According to Ben Baumann, Co-Founder and Chief Operating Officer at OpenClinica, LLC “Our model provides inherent flexibility that makes it possible to operate more efficient, lower cost clinical studies, while meeting strict regulatory requirements. We are excited to be working with the QCTBC.”

OpenClinica Media Contact:
Ben Baumann
+1 617-621-8585

Queensland Clinical Trials & Biostatistics Centre Media Contact:
Dr. Sanjoy Paul
+61-7-3176 5625

About The Queensland Clinical Trials & Biostatistics Centre (QCTBC)

The Queensland Clinical Trials & Biostatistics Centre (QCTBC) is a school centre within the School of Population Health. The Centre was formed in September 2009 with the goal of promoting and running high quality clinical, non-clinical and biostatistical methodological studies, both locally and internationally. The QCTBC provides the necessary expertise and infrastructure to design, conduct, and facilitate high quality clinical trials, non-trial clinical studies and biostatistical research with both academic and industry collaborators. All professionals of the Centre are GCP trained, and conduct clinical studies strictly following the regulatory requirements (FDA) and pharmaceutical industry standard. The Centre is currently running Phase 1, -2 and -3 clinical trials, leading several clinical studies including evaluation of cardiometabolic effects of new anti-diabetes drug (GLP-1R agonists), proteomics and metabolomics, and methodological studies in Clinical Biostatistics. In addition, the Centre provides high quality consulting services to clinical researchers and bio-pharmaceutical companies. More information at http://www.sph.uq.edu.au/qctbc.

About OpenClinica®

OpenClinica enhances the productivity of clinical trials through commercial open source software. Trusted by hundreds of biopharmaceutical companies, contract research organizations, academic, and government organizations worldwide, the OpenClinica software facilitates electronic data capture and data management, increasing the speed of collection and quality of data in clinical trials. OpenClinica supports HIPAA, 21 CFR Part 11, and other regulatory guidelines and is designed as a standards-based, extensible, and modular platform. For quick news and updates follow @OpenClinica on Twitter.